The Market and Potential for Molecular Point of Care 2021

    Published: January 22, 2021 | Price: $4,000 – $8,000

    This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche and Quidel compete, but there are many other and new entrants since our last reporting. Molecular point of care or mPOC systems are designed to be faster than lab-based tests while more accurate than existing point of care systems. Development of...
    The Market and Future Potential for Molecular Point of Care

    Published: March 11, 2020 | Price: $4,000 – $8,000

    THIS REPORT HAS A NEWER VERSION AVAILABLE: https://kaloramainformation.com/product/2021-molecular-point-of-care/   This report provides market sizing, forecasting, trend mapping and competitive analysis for point of care tests using PCR or other molecular technology with fast turnaround times and usability in near-patient settings. Major IVD companies such as Abbott and Roche compete in this segment, influenza competitors Sekisui and Quidel also operate, as do specialty concerns such as Curetis, Biocartis, and a host of small but innovative players. Molecular point of care or...
    IVD Market Trends Summary

    Published: April 26, 2019 | Price: $3,000 – $6,000

    In vitro diagnostic (IVD) products continue to see positive sales growth in many categories, while others mature. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture. IVD Market Trends Summary features current trends and updates in the worldwide IVD market. Highlights of these updates include: Market developments in developing markets – Latin America, the Middle East and Eastern Europe Effects of PAMA in...